HomePRLD • NASDAQ
add
Prelude Therapeutics Inc
Previous close
$3.59
Day range
$3.49 - $3.71
Year range
$1.66 - $5.83
Market cap
192.25M USD
Avg Volume
55.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 34.34M | 17.96% |
Net income | -31.43M | -13.40% |
Net profit margin | — | — |
Earnings per share | -0.42 | 27.59% |
EBITDA | -33.92M | -17.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 201.92M | 17.22% |
Total assets | 247.11M | 24.60% |
Total liabilities | 36.37M | 57.98% |
Total equity | 210.73M | — |
Shares outstanding | 54.93M | — |
Price to book | 0.93 | — |
Return on assets | -32.72% | — |
Return on capital | -35.60% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -31.43M | -13.40% |
Cash from operations | -31.79M | -5.50% |
Cash from investing | 31.22M | 73.46% |
Cash from financing | -14.00K | 94.80% |
Net change in cash | -584.00K | 95.29% |
Free cash flow | -21.46M | -48.76% |
About
Founded
2016
Headquarters
Website
Employees
128